Cargando…

Immunotherapy in Breast Cancer: the New Frontier

PURPOSE OF REVIEW: This review summarizes current immunotherapies in breast cancer, with an emphasis on immune checkpoint inhibitors and vaccines. RECENT FINDINGS: Combination immunotherapy with checkpoint inhibitors and cytotoxic therapies have shown promising results. Active clinical trials are on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Zishuo I., McArthur, Heather L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Translational Research (RL Aft, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970253/ https://www.ncbi.nlm.nih.gov/pubmed/29881518 http://dx.doi.org/10.1007/s12609-018-0274-y

Ejemplares similares

The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer?
por: Hu, Zishuo I., et al.
Publicado: (2017)

The 2014 San Antonio Breast Cancer Symposium: A successful lift-off for breast immunotherapy?
por: Page, David B, et al.
Publicado: (2015)

Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment
por: Turri-Zanoni, Mario, et al.
Publicado: (2022)

Donation After Circulatory Death: A New Frontier
por: Joshi, Yashutosh, et al.
Publicado: (2022)

Mast Cells: A New Frontier for Cancer Immunotherapy
por: Lichterman, Jake N., et al.
Publicado: (2021)

Nutrition in the Neurocritical Care Unit: a New Frontier
por: Tavarez, Tachira, et al.
Publicado: (2021)

Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer
por: Ruf, P, et al.
Publicado: (2007)

The Gut Microbiome: a New Frontier in Musculoskeletal Research
por: Li, R., et al.
Publicado: (2021)

Beyond traditional frontiers: robotic total pelvic exenteration
por: Tamhankar, Ashwin Sunil, et al.
Publicado: (2020)

Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
por: Rahman, Masmudur M., et al.
Publicado: (2021)

Vaccines and immunotherapy against fungi: the new frontier
por: Nosanchuk, Joshua D., et al.
Publicado: (2013)

Immunotherapy for sarcomas: new frontiers and unveiled opportunities
por: Birdi, Harsimrat Kaur, et al.
Publicado: (2021)

Tissue oxygen saturation predicts response to breast cancer neoadjuvant chemotherapy within 10 days of treatment
por: Cochran, Jeffrey M., et al.
Publicado: (2018)

Using macrophage activation to augment immunotherapy of established tumours
por: Fridlender, Z G, et al.
Publicado: (2013)

Immunotherapy Frontiers in Hematology
por: Hallam, Simon
Publicado: (2017)

Epigenetics—New Frontier for Alcohol Research
por: Shukla, Shivendra D., et al.
Publicado: (2013)

Immunotherapy for Non-melanoma Skin Cancer
por: Shalhout, Sophia Z., et al.
Publicado: (2021)

Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice
por: Chandra, D, et al.
Publicado: (2013)

Correction: Immunotherapy for sarcomas: new frontiers and unveiled opportunities
Publicado: (2022)

Aromatase inhibitor strategies in metastatic breast cancer
por: McArthur, Heather L, et al.
Publicado: (2010)

Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy
por: Bhave, Prachi, et al.
Publicado: (2023)

Very high-risk prostate cancer: multimodality treatment will be the new frontier
por: Campobasso, Davide, et al.
Publicado: (2017)

Frontiers in antiviral therapy and immunotherapy
por: Heaton, Steven M
Publicado: (2020)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
por: Emens, Leisha A, et al.
Publicado: (2021)

Robotic radical nephrectomy and level II inferior vena cava thrombectomy: exploring the newer frontiers
por: Ahluwalia, Puneet, et al.
Publicado: (2020)

Optimizing (neo)adjuvant treatment of HER2-positive breast cancer
por: Basho, Reva K., et al.
Publicado: (2018)

New Instruments
Publicado: (1893)

Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?
por: Sumransub, Nuttavut, et al.
Publicado: (2021)

Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy
por: Zhang, Minchuan, et al.
Publicado: (2023)

Flavonoids: New Frontier for Immuno-Regulation and Breast Cancer Control
por: Sudhakaran, Meenakshi, et al.
Publicado: (2019)

A New Factor in Erosion
por: Underwood, Arthur S.
Publicado: (1898)

Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma
por: Cho, Shih-Feng, et al.
Publicado: (2021)

A New Tæniafuge
por: Campi, Numa, et al.
Publicado: (1886)

A New Generation of Vaccines in the Age of Immunotherapy
por: Addeo, Alfredo, et al.
Publicado: (2021)

A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate
por: Scandlyn, M J, et al.
Publicado: (2008)

Triplet Therapy in Melanoma — Combined BRAF/MEK Inhibitors and Anti-PD-(L)1 Antibodies
por: Dixon-Douglas, Julia R., et al.
Publicado: (2022)

On Some New Local Anesthetics
por: Braun, H.
Publicado: (1906)

Some New Lanoline Ointments
por: Stern, E., et al.
Publicado: (1889)

New Facts about Antipirine
Publicado: (1885)

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6rposn794a62ff2s60fv97sh9h